Abstract P228: Preclinical pharmacokinetics and pharmacodynamics of KB-0742, a selective, oral CDK9 inhibitor
Work
Year: 2021
Type: article
Source: Molecular Cancer Therapeutics
Cites:
Cited by: 6
Related to: 10
FWCI: 0.507
Citation percentile (by year/subfield): 56.1
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed